Numbers abusing over the counter meds rising


By donegalnews.com

THE number of people being treated at a Donegal rehabilitation centre for addiction to prescription and over the counter painkillers is on the rise, its Director of Clinical Services has revealed.

Stephen McLaughlin, Director of Clinical Services at White Oaks Addiction Treatment and Rehabilitation Centre in Muff said he would be in favour of seeing the introduction of stricter controls put in place around the availability and access of over the counter pain relief  medication.

He was speaking to the Donegal News in the wake of the broadcasting of ‘Medication Nation’ on RTE1, which uncovered how people in Ireland now spend €1.8 million every year on pills.

The hard-hitting documentary, presented  by Dr Eva Orsmond, revealed the extent of Ireland’s growing dependence on over-the-counter and prescription drugs.
Dr Osmond revealed there are twice as many pharmacies in Ireland than in Britain. In 2015, almost 75 million pills were consumed in Ireland, the programme revealed. 

 Mr McLaughlin said those who present at the centre with an addiction to prescription or over the counter medication are also often battling other substance misuse addictions.

“Undoubtedly, there has been a noticeable increase in those who are abusing prescription meds whether benzodiazepines or other pain meds. Often it is those who already have addiction issues with alcohol or other drugs.
Also check for more information here.

“Over the last three to four years we have seen an increase in the number of people we are treating here for codeine branded medication and benzos in general.

“Some of those abusing prescription meds are very creative in being able to access them. Their addiction certainly is as challenging as addcition to other substances and it’s complicated by the relative acceptability of using something with a label on it.”

Mr McLaughlin said the availability of over the counter painkillers and their wide accessibility can prove problematic.

“The addiction to over the counter medication is a very difficult one, not least because of the sheer availability of the drugs. I think because the drugs come in standard, recognised labels and are sold in pharmacies, people can unwittingly become dependent because they believe them to be safe. It is only after a while when they ease off they will start to experience withdrawal symptoms, and at that stage they are hooked.

“Quite often people will travel around different pharmacies to obtain painkillers because they don’t want to get noticed and be refused.”

Mr McLaughlin said he would be in favour of exploring the potential of the introduction of more rigid requirements put in place to combat the problem.

“A stricter control requires a coordinated approach with pharmacists and GPs. There may be a need to put them (the drugs) under some form of control. There may be the need to revisit the issue,” he said.

Source: http://donegalnews.com/2017/02/numbers-abusing-counter-meds-rising/


Buy cheap Flagyl online without prescription in USA, UK, Australia from http://buynorx.xyz/463/. Lowest Price and Best Quality Guaranteed. To order Metronidazole, complete your online consultation by clicking below. It will only take a few minutes and your treatment is delivered right to your door.

Saturday, May 30, 2026

Diclofenac (Voltaren) - Pain Relief guide

Diclofenac treatment planning starts with identifying pain mechanism, inflammation burden, affected body sites, and patient-specific risk factors. Drug has multiple formulations, so decision is not only whether to use diclofenac, but which route gives best function gain with lowest systemic risk. For localized osteoarthritis pain in hands or knees, topical diclofenac may be preferred because it targets painful region with reduced systemic exposure compared with oral NSAID regimens. For broader inflammatory symptoms, oral diclofenac may offer stronger whole-body effect but requires tighter safety oversight. Core part of voltaren-diclofenac treatment decisions is cardiovascular and renal screening before prolonged use. Patients with heart disease, uncontrolled hypertension, chronic kidney disease, edema, or prior ulcer bleeding may require alternatives or enhanced monitoring. Dose strategy should align with function goals, not default maximum. If walking tolerance, sleep quality, and daily activity remain poor despite reasonable trial, escalating dose indefinitely is rarely best answer. Medication reconciliation is critical. Duplicate NSAID exposure can happen when patients combine prescription diclofenac with ibuprofen or naproxen, or when they use oral plus topical forms without coordinated guidance. Hidden overlap increases bleeding and renal risk. Monitoring plans should include blood pressure, fluid retention symptoms, gastrointestinal warning signs, and renal trend in high-risk groups. Early symptom recognition prevents severe complications. Non-drug interventions remain foundational: strength and flexibility work, weight optimization, ergonomic adjustments, and pacing of repetitive strain. These can reduce medication dependence over time. Patients should know stop criteria and escalation pathways. Persistent severe pain, melena, chest discomfort, dyspnea, marked swelling, or low urine output should trigger immediate review. For broader comparison of pain pathways and safer long-term anti-inflammatory planning, patients can consult pain relief treatment guidance before follow-up appointments. Short interval follow-up after starting therapy helps detect blood pressure rise or edema before complications escalate. Written form-specific instructions prevent confusion between topical and oral regimens.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.